Skip to content

Evaluating the clinical effectiveness of CEREBO in traumatic brain injury management

Investigating the Clinical Efficacy of CEREBO for early detection of Traumatic Brain Injury - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071021
Enrollment
198
Registered
2024-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S068- Other specified intracranial injuries

Interventions

Intervention1: CEREBO: Participants in the experimental group will undergo a one-time scan with the CEREBO device prior to receiving their standard care during triaging. The scanning process is brief,

Sponsors

Indian Council of Medical Research
Lead Sponsor
Bioscan Research Pvt Ltd
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Traumatic brain injury patients arriving at the emergency department and referred for a head CT scan

Exclusion criteria

Exclusion criteria: History of neurosurgical procedure (e.g. decompressive craniectomy) with residual bone flap

Design outcomes

Primary

MeasureTime frame
To evaluate the triaging efficacy of CEREBO® by calculating the 1. Sensitivity 2. Specificity 3. Accuracy 4. Positive Predictive Value 5. Negative Predictive ValueTimepoint: 3 years

Secondary

MeasureTime frame
To assess the usability of CEREBO® among healthcare professionals through survey questionnairesTimepoint: 3 years;To evaluate the utility of CEREBO® in reducing the mean transfer time from triage to treatmentTimepoint: 3 years

Countries

India

Contacts

Public ContactDr Vedang Mahajan

All India Institute of Medical Sciences, Delhi

skale67@gmail.com9811426806

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026